Skip to main content
logo
Sun Pharmaceutical Industries Limited (BOM:524715)
India flag India · Delayed Price · Currency is INR
1,700.85
-26.85 (-1.55%)
At close: Jul 16, 2025

BOM:524715 Revenue

In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B INR with 8.42% growth. Sun Pharmaceutical Industries had revenue of 129.59B in the quarter ending March 31, 2025, with 8.14% growth.

Revenue
525.78B
Revenue Growth
+8.42%
P/S Ratio
7.88
Revenue / Employee
12.23M
Employees
43,000
Market Cap
4,144.85B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025525.78B40.82B8.42%
Mar 31, 2024484.97B46.11B10.51%
Mar 31, 2023438.86B52.31B13.53%
Mar 31, 2022386.54B51.56B15.39%
Mar 31, 2021334.98B6.61B2.01%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Reliance Industries9,646.93B
HDFC Bank2,728.47B
Tata Consultancy Services2,561.48B
Bharti Airtel1,729.85B
ICICI Bank2,006.54B
State Bank of India3,429.39B
Infosys1,647.16B
Hindustan Unilever631.21B
Revenue Rankings

Sun Pharmaceutical Industries News

More News